MRP

General Information


DRACP ID  DRACP00095

Peptide Name   MRP

Sequence  AIGSILGALAKGLPTLISWIKNR

Sequence Length  23

UniProt ID  Not available

PubChem CID  Not available

Origin  Rana tagoi

Type  Native peptide

Classification

  

Active ACP Membrane-targeted



Activity Information


Cell Line Disease Cancer Classified Activity Assay Testing Time Literature
EL4 T-lymphoma T-cell lymphoma Lymphoma LC50=14 μM Trypan blue assay 1 h 1

Hemolytic Activity  Human erythrocytes: HC50=8 μM

Normal (non-cancerous) Cytotoxicity  L929: LC50=20 μM

Target  Not available

Affinity  Not available

Mechanism  Not available

Nature  Anticancer; Antibacterial; Antifungal



Structure Information


PDB ID  Not available

Predicted Structure  DRACP00095

Helicity  Not available

Linear/Cyclic  Linear

Disulfide/Other Bond  Not available

N-terminal Modification  Free

C-terminal Modification  Amidation

Other Modification  None

Chiral  L



Physicochemical Information


Formula  C111H190N30O28

Absent amino acids  CDEFHMQVY

Common amino acids  IL

Mass  278553

Pl  11.82

Basic residues  3

Acidic residues  0

Hydrophobic residues  12

Net charge  3

Boman Index  791

Hydrophobicity  73.04

Aliphatic Index  148.7

Half Life 
  Mammalian: 1.3 hour
  Yeast: 3 min
  E.coli: 2 min

Extinction Coefficient cystines  5500

Absorbance 280nm  250

Polar residues  7

Amino acid distribution



Literature Information


Literature 1

Pubmed ID 12804591

Title  A melittin-related peptide from the skin of the Japanese frog, Rana tagoi, with antimicrobial and cytolytic properties

Doi 10.1016/s0006-291x(03)00999-9

Year  2003

Patent

Patent ID Not available

Patent Title  Not available

Other Iinformation  Not available

Other Published ID  Not available




DRACP is developed by Dr.Zheng's team.